The Value of Biological Markers in Assessing the Severity of Community-Acquired Pneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Value of Biological Markers in Assessing the Severity of Community-Acquired Pneumonia

Published:2023 Issue:12 Volume:13 Page:19429-19436
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

骆少琦

Publisher

Hans Publishers

Subject

General Engineering

Reference50 articles.

1. Discordance of physician clinical judgment vs. pneumonia severity index (PSI) score to admit patients with low risk community-acquired pneumonia: a prospective multicenter study

2. A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia

3. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

4. 王纯, 蔡燕, 虞志新. 双歧杆菌四联活菌辅助头孢哌酮钠舒巴坦钠对重症肺炎的临床疗效[J]. 系统医学, 2022, 7(19): 27-31.

5. 刘士琛. 肺炎合并低氧血症性呼吸衰竭患者进展为ARDS危险因素研究[D]: [硕士学位论文]. 重庆: 中国人民解放军陆军军医大学, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP